Edition:
India

CVS Health Reports Q3 GAAP EPS From Continuing Operations Of $1.36


Tuesday, 6 Nov 2018 

Nov 6 (Reuters) - CVS Health Corp ::Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36 .CVS HEALTH CORP QTRLY NET REVENUES INCREASED 2.4% TO $47.3 BILLION.CVS HEALTH CORP QTRLY ADJUSTED EPS OF $1.73.CVS HEALTH CORP SEES 2018 GAAP DILUTED EPS FROM CONTINUING OPERATIONS OF $1.40 TO $1.50.CVS HEALTH CORP SEES 2018 ADJUSTED EPS OF $6.98 TO $7.08.CVS HEALTH CORP SEES 2018 CASH FLOW FROM OPERATIONS OF ABOUT $9.0 BILLION; FREE CASH FLOW OF APPROXIMATELY $7.0 BILLION.CONFIRMED FULL YEAR GUIDANCE.CVS HEALTH CORP QTRLY SAME STORE SALES INCREASED 6.7% AND PHARMACY SAME STORE SALES INCREASED 8.7% IN THE QUARTER ENDED SEPT 30, 2018.FRONT STORE SAME STORE SALES INCREASED 0.8% IN THE QUARTER ENDED SEPT 30, 2018, COMPARED TO THE SAME QUARTER OF THE PRIOR YEAR.Q3 GAAP EPS FROM CONTINUING OPERATIONS OF $1.36.REGULATORY APPROVAL PROCESS FOR AETNA DEAL IS PROCEEDING WITHIN TIMEFRAME CONSISTENT WITH EXPECTATIONS.IN Q2 CO HAD $3.9 BILLION GOODWILL IMPAIRMENT CHARGE RELATED TO LTC BUSINESS. 

Company Quote

0.59
0.0 +0.00%
12:25am IST